Internal Medicine, Rheumatology · New Iberia, LA
NPI
1659456242
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2312 E Main St, Ste C
New Iberia, LA, 70560
Phone (337) 560-1711
Groups this clinician bills Medicare through
Medicare paid, 2023
$40K
540 services
Medicare patients, 2023
291
Average age 68
Drug cost, 2024
$11.0M
16,889 prescriptions
Company payments, 2025
$3,157
From 17 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Bernard S Hojaili was code 99214 (office e&m - established), 374 times for 221 patients. In total Bernard S Hojaili billed 540 services in 11 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 374 | 221 | $68.03 | $25K |
| 99204 Office E&M - New | Facility | 126 | 126 | $92.17 | $12K |
| 99213 Office E&M - Established | Facility | 17 | 16 | $47.83 | $813 |
By year: 2022 $40K for 538 services; 2023 $40K for 540 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bernard S Hojaili prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,580 prescriptions and refills. In total Bernard S Hojaili wrote 16,889 Medicare prescriptions that cost $11.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,580 | 2,387 | 378 | $46K |
| Methotrexate Methotrexate Sodium | 1,249 | 2,069 | 303 | $17K |
| Gabapentin Generic | 1,105 | 1,593 | 249 | $14K |
| Tizanidine Hcl Generic | 1,021 | 1,514 | 252 | $7,327 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,012 | 1,013 | 131 | $26K |
| Omeprazole Generic | 912 | 1,521 | 237 | $8,894 |
| Prednisone Generic | 874 | 1,154 | 205 | $3,346 |
| Zolpidem Tartrate Generic | 570 | 730 | 125 | $4,367 |
| Pregabalin Generic | 523 | 706 | 123 | $15K |
| Mycophenolate Mofetil Generic | 474 | 635 | 93 | $56K |
| Leflunomide Generic | 432 | 728 | 128 | $15K |
| Tramadol Hcl Generic | 427 | 446 | 93 | $3,164 |
| Humira(Cf) Pen Adalimumab | 426 | 426 | 58 | $4.5M |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 382 | 382 | 43 | $12K |
| Duloxetine Hcl Generic | 369 | 587 | 88 | $5,980 |
Brand drugs: - claims; generic drugs: 15,280 claims; opioid claims: 1,855.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bernard S Hojaili $3,157 ($3,157 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $1,096.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 40 | $1,096 |
| Mallinckrodt Hospital Products Inc. | 13 | $376 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $373 |
| Amgen Inc. AMGN | 18 | $285 |
| ANI Pharmaceuticals, Inc. ANIP | 12 | $236 |
| Janssen Biotech, Inc. JNJ | 7 | $181 |
| GlaxoSmithKline, LLC. GSK | 9 | $167 |
| Cardinal Health 110 LLC | 1 | $100 |
| UCB, Inc. UCB.BR | 4 | $83.73 |
| Pfizer Inc. PFE | 4 | $78.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.